« Previous
Next »
Journal of the American College of Surgeons
Volume 210, Issue 2
, Pages
199-204
, February 2010
Safety and Immunogenicity Observations Pooled from Eight Clinical Trials of Recombinant Human Thrombin
To access this article, please choose from the options below
The clinical trials were supported in full by ZymoGenetics.
Disclosure Information: Dr Alexander is a salaried employee and holds an ownership interest in ZymoGenetics, Inc, and Dr Weaver is a speaker who has received honoraria from ZymoGenetics, Inc. The other authors have nothing to disclose.
ClinicalTrials.gov: NCT00491608, NCT00371215, NCT00245336.
PII: S1072-7515(09)01458-6
doi: 10.1016/j.jamcollsurg.2009.09.042
© 2010 American College of Surgeons. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of the American College of Surgeons
Volume 210, Issue 2
, Pages
199-204
, February 2010
